Viewing Study NCT00258557


Ignite Creation Date: 2025-12-24 @ 6:55 PM
Ignite Modification Date: 2026-01-01 @ 6:40 PM
Study NCT ID: NCT00258557
Status: COMPLETED
Last Update Posted: 2013-06-26
First Post: 2005-11-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications.
Sponsor: Tibotec Pharmaceuticals, Ireland
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV View
None Anti-Retroviral agents View
None HIV-1 View
None TMC114/r View
None Treatment naïve patients View